Urszula Adamiak-Giera

CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers

B Gawrońska-Szklarz, Urszula Adamiak-Giera, Elżbieta Wyska et al. · European Journal of Clinical Pharmacology · 2012 · 66 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +13

Pharmacokinetics of Levodopa in Patients With Parkinson Disease and Motor Fluctuations Depending on the Presence of Helicobacter pylori Infection

Ewa Narożańska, Monika Białecka, Urszula Adamiak-Giera et al. · Clinical Neuropharmacology · 2014 · 45 citations

Medicine, Pharmacokinetics, Pharmacology +15

Epilobium angustifolium L. Extracts as Valuable Ingredients in Cosmetic and Dermatological Products

Anna Nowak, Martyna Zagórska-Dziok, Paula Ossowicz‐Rupniewska et al. · Molecules · 2021 · 45 citations · Full text

Life Sciences, Botany, Plant Sciences +12

Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease

Urszula Adamiak-Giera, Maria Kałdońska, Gabriela Kłodowska-Duda et al. · Clinical Neuropharmacology · 2010 · 31 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Assessment of the Effect of Structural Modification of Ibuprofen on the Penetration of Ibuprofen from Pentravan® (Semisolid) Formulation Using Human Skin and a Transdermal Diffusion Test Model

Paula Ossowicz‐Rupniewska, Anna Nowak, Joanna Klebeko et al. · Materials · 2021 · 29 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16